Cancer clinical trials in the region Occitanie

174 currently recruiting clinical trials
Region Occitanie

Phase 2 Lung cancer
#NCT03915678
NSCLC (Non-Small Cell Lung Cancer) Metastatic Immunotherapy 1 2 3 or more
Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
Institut Bergonié
Phase 2 Liver and bile duct cancer
#NCT03727633
Hepatocellular carcinoma Localized Systemic Treatment-Naive None Unhealthy A B A B C
8 main criterias to confirm
Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
CHU de Montpellier
Phase 2 Liver and bile duct cancer
#NCT03475953
Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
4 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2 Breast cancer
#NCT03475953
HER2 Negative HR Negative Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive Immunotherapy Bispecific T-cell engager antibodies
6 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2 Lung cancer
#NCT03475953
NSCLC (Non-Small Cell Lung Cancer) Mesothelium Non-squamous NSCLC Locally Advanced Metastatic Immunotherapy Chemotherapy Targeted therapy Antibody Drug Conjugates (ADC) 1 2 3 or more
ALK EGFR ROS-1 Systemic Treatment-Naive
8 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2 Kidney cancer
#NCT03475953
Other Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2 Kidney cancer
#NCT03475953
Clear cell carcinoma Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2 Colon cancer Rectal cancer
#NCT03475953
Locally Advanced Metastatic Immunotherapy Chemotherapy Targeted therapy Antibody Drug Conjugates (ADC) 1 2 3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2 Stomach and esophageal cancer
#NCT03475953
Stomach Esophagus Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2 Breast cancer
#NCT03424005
HER2 Low HER2 Positive HR Positive Locally Advanced Metastatic PIK3CA 1 2 3 or more
Systemic Treatment-Naive
7 main criterias to confirm
IUCT Oncopôle (Toulouse)
Hoffmann-La Roche